Michael Feld - 26 Nov 2024 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Role
EVP & President, Life Sciences
Signature
Donna Kalazdy, by power of attorney from Michael Feld
Issuer symbol
BDX
Transactions as of
26 Nov 2024
Net transactions value
$0
Form type
4
Filing time
29 Nov 2024, 10:00:29 UTC
Previous filing
21 Aug 2024
Next filing
22 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDX Common Stock Award $0 +2,553 +38% $0.000000 9,190 26 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDX Stock Appreciated Rights Award $0 +10,004 $0.000000 10,004 26 Nov 2024 Common Stock 10,004 $224.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2 The stock appreciation rights vest in four annual installments beginning November 26, 2025.